Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.

Radionetics initiates its first clinical program targeting MC2R

News | Radiation Oncology

Radionetics Oncology Announces Initiation of Phase 1 Radiopharmaceutical Program Against a Novel Target for Adrenocortical Carcinoma

October 17, 2023 — Radionetics Oncology, Inc., a clinical stage radiopharmaceutical company focused on the discovery and ...

October 17, 2023

A global licensing agreement has been signed for the development and commercialization of SOFIE’s two investigational Gallium-68 and Fluorine-18 Fibroblast Activation Protein Inhibitors (FAPI) radiopharmaceutical diagnostics - [68Ga]FAPI-46 and outside-U.S. rights for [18F]FAPI-74

News | Radiopharmaceuticals and Tracers

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE) ...

October 11, 2023

68Ga-ABY-025 PET/CT and 18F-FDG PET/CT images at baseline with 18F-FDG PET/CT follow-up after 2 cycles of treatment in biopsy-confirmed HER2-positive disease

News | Breast Imaging

Whole-body PET/CT Predicts Response to HER2-targeted Therapy in Metastatic Breast Cancer Patients

October 11, 2023 — A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth ...

October 11, 2023

Sponsored Content

Videos | Proton Therapy

HYPERSCAN: Pencil Beam Scanning Delivered at Hyper Speed

Introducing HYPERSCAN , Pencil Beam Scanning Delivery HYPERSCAN enables tumor volumes to be scanned in a matter of ...

October 06, 2014

A modern collection of imaging innovations offers a new path to healthcare and medical research, framing a new era of medical diagnostic solutions

Feature | Magnetic Resonance Imaging (MRI) | By Robert L. Bard, MD, and Lennard M. Gettz, EdD

The Full Body Imaging Movement: A Strategic Upgrade of the MRI

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

September 25, 2023

Advancements in research, technology and partnerships are combining to enhance availability and access

Feature | Proton Therapy | By Christine Book

Targeting Cancer, Tracking Collaboration: A Progress Report on Proton Therapy

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

September 21, 2023

This molecule may significantly expand the patient population eligible for SCINTIX therapy to patients with solid tumor cancers of any stage in a manner that may improve both outcomes and procedural workflow

News | Radiation Therapy

RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

September 20, 2023

A the COVID-19 public health emergency continues to evolve, SNMMI issues updated guidance

News | SNMMI

SNMMI Issues Updated Statement: COVID-19 and V/Q Lung Studies

September 18, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), as a professional society ...

September 18, 2023

The clinical study of Positron’s Affinity PET-CT is designed to provide key information that evaluate the new system and its full capabilities with multiple radiopharmaceuticals and new coronary flow software applications that will enhance physician’s diagnostic analysis

News | PET-CT

Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device

September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...

September 08, 2023

The AURA 10 is now poised to help enhance surgical outcomes in the United States

News | PET-CT

XEOS Receives Approval by US FDA for the AURA 10 PET-CT Specimen Imager for the Operating Room

September 7, 2023 — The groundbreaking AURA 10 specimen imager by Belgian MedTech pioneer XEOS has been cleared by the ...

September 07, 2023

Feature | PET Imaging

PET Radiotracer Market anticipated to reach $3.2 Billion in Revenues by 2031

According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...

September 05, 2023

NorthStar’s high purity non-carrier added (n.c.a.) Ac-225 to be used in Curadh’s molecularly targeted radiation (MTR) programs for treatment of solid tumors

News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes and Curadh MTR Announce a Strategic Long Term Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

August 31, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

August 31, 2023

First participant of cohort 4 of the theranostic CL04 trial investigating 64Cu/67Cu SARTATE in neuroblastoma has been treated at the highest dose cohort of 375MBq/kg body weight using NorthStar’s electron accelerator-produced Cu-67, marking a key milestone in NorthStar’s agreement to exclusively supply Cu-67 to Clarity

News | Radiopharmaceuticals and Tracers

First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma

August 29, 2023 — NorthStar Medical Radioisotopes, LLC (“NorthStar"), a global innovator in the development, production ...

August 29, 2023

News | Radiopharmaceuticals and Tracers

Carolina Breast Imaging Specialists, PLLC Is First in Nation to Adopt Groundbreaking Imagio Breast Imaging System for Breast Cancer Diagnosis

August 29, 2023 — Mammograms are an essential part of preventive healthcare, and when an initial review reveals a ...

August 29, 2023

Strategic collaboration signed to support the development of radiopharmaceuticals in the fight against cancer

News | Radiopharmaceuticals and Tracers

PanTera and TerraPower Isotopes Join Forces to Accelerate Access to Actinium-225

August 28, 2023 — TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK CEN and IBA, announced that ...

August 28, 2023